← Back to screener

AtriCure, Inc. ATRC

Rank #2124 · Nasdaq · $3.1B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
32.9
P/E
-101.9
P/B
6.79
ROE
-6.7%
Op. Margin
-6.7%
Debt Ratio
32%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E -101.9x, P/B 6.79x. Ranks in the top 72% of the universe.

Profitability ★☆☆☆☆
Weak

ROE -6.7%. Ranks in the top 76% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 32%. Ranks in the top 18% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆
Excellent

Revenue growth of 20.8% year over year. Ranks in the top 18% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.1B$-0.0B$-0.0B$0.0B-28.458
2012$0.1B$-0.0B$-0.0B$0.0B-5.4107
2013$0.1B$-0.0B$-0.0B$0.0B-7.3119
2014$0.1B$-0.0B$-0.0B$0.0B-10.2252
2015$0.1B$-0.0B$-0.0B$0.0B-13.3207
2016$0.1B$-0.0B$-0.0B$0.1B-15.2119
2017$0.1B$-0.0B$-0.0B$0.1B-20.681
2018$0.2B$-0.0B$-0.0B$0.2B-20.157
2019$0.2B$-0.0B$-0.0B$0.2B-14.364
2020$0.2B$-0.0B$-0.0B$0.2B-8.5193
2021$0.2B$-0.0B$-0.0B$0.2B-14.4121
2022$0.2B$-0.0B$-0.0B$0.2B-21.453
2023$0.3B$0.1B$0.1B$0.4B20.131
2024$0.3B$-0.0B$-0.0B$0.5B-12.931
2025$0.4B$-0.0B$-0.0B$0.5B-6.732

← See the full screener